Research ArticleArticle
Rimonabant, a CB1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating LKB1 and AMPK Axis Downstream of Gαi/o Inhibition
Hong Min Wu, Yoon Mee Yang and Sang Geon Kim
Molecular Pharmacology July 29, 2011, mol.111.072769; DOI: https://doi.org/10.1124/mol.111.072769